UPLOAD Filing
HOOKIPA Pharma Inc.
Date: July 7, 2025 · CIK: 0001760542 · Accession: 0000000000-25-007088
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-38869
Letter
Re: HOOKIPA Pharma Inc. Preliminary Proxy Statement on Schedule 14A Filed June 16, 2025 File No. 001-38869 Dear Malte Peters:
July 7, 2025
Malte Peters Chief Executive Officer HOOKIPA Pharma Inc. 350 Fifth Avenue, 72nd Floor, Suite 7240 New York, NY 10118
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
cc: David Brinton, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 7, 2025 Malte Peters Chief Executive Officer HOOKIPA Pharma Inc. 350 Fifth Avenue, 72nd Floor, Suite 7240 New York, NY 10118 Re: HOOKIPA Pharma Inc. Preliminary Proxy Statement on Schedule 14A Filed June 16, 2025 File No. 001-38869 Dear Malte Peters: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David Brinton, Esq. </TEXT> </DOCUMENT>